Appyea, Inc

Market Cap $6.37M
Debt $1.26M
Cash $56.00K
EV $7.57M
FCF $NaN

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	-$1.31M
EBIT	-$1.83M
ROA	-526%
Equity	-$2.17M
Growth Stability	1
PE	-4.88
PB	-2.94
Price/Cash	0.01
Debt/Equity	-0.58
Net Margins	-10K%
Sales Growth QoQ	-50%
Sales CAGR	-2%
Equity CAGR	-1%

Earnings Growth YoY	-65%
Earnings Growth QoQ	-383%
Sales CAGR 5Y	-3%
Market Cap	$6.37M
Assets	$347.00K
Total Debt	$1.26M
Cash	$56.00K
Shares Outstanding	439.21M
EV	7.57M
Shares Growth 3y	10%
Equity Growth QoQ	1%
Equity Growth YoY	-34%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

AppYea, Inc. operates as a digital health company that develops wearable monitoring solutions to treat sleep apnea and snoring. It develops SleepX App, a wristband communicating with its smartphone app that trains the brain to breath properly; DreamIT, a biofeedback snoring treatment wristband; SleepX PRO, a smartphone application that monitors breathing patterns in the sleep and identify sleep arena episode without direct contact to the user; and DreamIT PRO, a wristband for the treatment of sleep arena using biofeedback in combination with SleepX PRO app. The company was founded in 2012 and is based in Rehovot, Israel.

SEC Filings

Direct access to Appyea, Inc (APYP) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2023
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2022
- 10-K Dec 31
- 10-Q Sep 30

Sector Comparison

How does Appyea, Inc compare to its competitors?

Not enough data to generate a comparison chart between Appyea, Inc and its competitors. Please check back later.

Peter Lynch's Chart

This chart shows the current pricing of Appyea, Inc compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

loading chart...

Appyea, Inc Discounted Cash Flow

Fully customizable DCF calculator online for Appyea, Inc.

Years

Calculation mode

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
DCF		$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Value	$0

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	06/2015	06/2016	06/2017	06/2018	06/2019	12/2021	12/2022	12/2023	TTM
Net Margins	-25K%	-48K%	-70K%	-47K%	-309K%	-	-	-	-10K%
ROA	-	-2K%	-669%	-1K%	-300%	-142%	-636%	-346%	-526%
ROE	-	-5K%	169%	108%	109%	132%	51%	72%	-

Bad Net Margins (-9.84K%)

Net Margins are too low to guarantee profitability in case of higher costs or higher interest rates. Furthermore lower margins cause higher earnings’ volatility.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	06/2015	06/2016	06/2017	06/2018	06/2019	12/2021	12/2022	12/2023	TTM
Debt over FCF	-	-	-	-	-	-	-	-	-
Debt over Equity	0.07	0.01	-1.21	-0.34	-0.63	-0.97	-0.6	-0.47	-0.58
Growth Stability	-	-	-	-	-	-	-	-	1

Neutral Debt/FCF ratio (-)

Net Margins are at a level that is not too high nor too low. They are not a competitive advantage but they are not a competitive disadvantage either.

Good Debt/Equity ratio (-0.58)

The company is not overleveraged and has a good balance between equity and debt.

Good Graham’s Stability (1)

The company has a good stability in its earnings, which is a sign of a good competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	06/2015	06/2016	06/2017	06/2018	06/2019	12/2021	12/2022	12/2023	CAGR 5Y
Revenue YoY growth	-	51%	-84%	327%	-92%	-	-	-	-3%
Earnings YoY growth	-	188%	-76%	185%	-47%	199%	-59%	39%	-
Equity YoY growth	-	-95%	-760%	345%	-47%	148%	6%	-0%	-
FCF YoY growth	-	-	-	-	-	-	-	-	-